Humanwell Healthcare | Briefing, News, Analysis, Research, Data

Humanwell Healthcare

Humanwell Healthcare insists on R&D as the guide

Humanwell Healthcare insists on R&D as the guide, and is at the forefront of R&D investment and new drug R&D progress among domestic pharmaceutical enterprises, and is committed to building a first-class platform for R&D and industrialization of new drugs in China.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Mar 30, 1993

HQ location

Hubei, China

Legal name

Humanwell Healthcare (Group) Co., Ltd.

Website

http://www.renfu.com.cn/

renfu.pr@renfu.com.cn

Employees

10001-50000

All
News
Analysis
Research

Briefing Apr 25, 2022 04:05 PM · Automotive | Technology | Healthcare

Nissan announced the progress of assisted driving technology, which can detect the deceleration traffic flow

Briefing Mar 10, 2022 03:59 PM · Real Estate | Technology | Healthcare

Meierya: elect Zheng Jiping as chairman and Duan Wenyan as general manager

In-depth

Healthcare

Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital

The investors have a partiality for the projects which could meet clinical needs, possess cutting-edge innovation technology and a talented team.

Yesterday 12:24 PM

Briefing Mar 09, 2022 04:49 PM · Financials | Automotive | Technology

Beijing: it is preliminarily believed that the source of infection of infected person 2 notified on the 8th is from other provinces

Briefing Feb 22, 2022 05:09 PM · Financials | Automotive | Healthcare

Dorui pharmaceutical: clinical approval documents for subsidiaries to purchase new drugs

Research

Healthcare, Technology, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Research

Healthcare, Technology, Consumer Staples

WIA2020 | Rising Tech Stars 2020: Global & China's 100

Dec 09, 2020 09:57 AM

Research

Healthcare

WIA2020 | Next 50 in Global Tech: Healthcare

Dec 09, 2020 09:39 AM

Research

Real Estate, Consumer Discretionary, Industrials

Tech for Global, Globalization Footprints of the Established and the New

May 29, 2020 08:30 PM

Briefing Feb 14, 2022 05:00 PM · Real Estate | Financials | Automotive

Optical cable: it is proposed to set up Jiangsu Tong Optoelectronics Technology, which is mainly engaged in raw material trade

Briefing Jan 21, 2022 06:09 PM · Healthcare | Technology

Zhangyu A: Sun Jian, director and general manager, increased 30000 B shares on January 21

Briefing Jan 05, 2022 03:49 PM · Financials | Automotive | Technology

China Merchants Steamship: Directors and senior executives plan to reduce their total holdings of no more than 904200 shares

Briefing Jan 04, 2022 04:29 PM · Technology | Healthcare | Consumer Staples

Riyue Co., Ltd. "construction project of finishing production line for key components of large offshore wind power with an annual output of 120000 tons" is planned to be postponed

In-depth

Healthcare

BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious

BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.

Jun 24, 2022 12:13 PM

Healthcare

Bio-based Materials Manufacturer Mojia Bio Nets USD 80 Mn in Series B Round

For synthetic biology companies, the bottlenecks are controlling the cost and achieving industrialization.

Jun 23, 2022 10:20 PM

Briefing Dec 06, 2021 03:39 PM · Technology | Healthcare

Hengrui medicine: a number of drugs have been approved to carry out clinical trials

Briefing Dec 03, 2021 03:59 PM · Technology | Healthcare | Consumer Staples

Alex: vometinib mesylate tablets are newly included in the national medical insurance catalogue

Briefing Nov 19, 2021 03:49 PM · Industrials | Financials | Technology

Humanwell pharmaceutical: it is proposed to transfer 2.52% shares of Huatai Insurance with RMB 1.026 billion

Healthcare

RNA Biotech Therorna Bags Over CNY 280 Mn in Series A Financing Round

Therorna, specialized in the development of cutting-edge circular RNA technology-based vaccines and therapies, will accelerate the development of a new broad-spectrum COVID-19 vaccine and other product pipelines with the fresh proceeds.

Jun 23, 2022 03:45 PM

Technology, Healthcare

Noah Hospital Logistics Robot Received over Ten Million CNY in Series B+ Round

Noah Hospital Logistics Robot recently received over ten million CNY in Series B+ round, with most of the funds going toward product development and marketing.

Jun 22, 2022 06:21 PM

Briefing Oct 18, 2021 01:06 AM · Financials | Consumer Staples

Three quarterly countdown institutions reward the bank sector configuration value

Briefing Oct 08, 2021 03:52 PM · Industrials | Automotive | Consumer Discretionary

Daqin Railway: in September, the freight volume of Daqin Railway decreased by 1.45% year-on-year

Briefing Sep 27, 2021 03:49 PM · Financials | Technology | Healthcare

West Gate: normal production and stable operation have been restored recently

Briefing Sep 17, 2021 03:50 PM · Technology | Healthcare

Xiangjiang Holdings: it plans to repurchase shares with no more than 145 million yuan

EqualOcean Analysis

EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.

Address

Beijing 9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai 2707-2708, AI Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China

New York Suite 2967, 29th Floor, 4 World Trade 150 Greenwich St, New York, NY 10006

About